HIGHLIGHTS
- who: Huideng Long and collaborators from the Department of Hematology, Zhongda Hospital, School of Medicine, Southeast University, Institute of Hematology Southeast University, Nanjing, China have published the research work: Azacitidine Is Synergistically Lethal with XPO1 Inhibitor Selinexor in Acute Myeloid Leukemia by Targeting XPO1/eIF4E/c-MYC Signaling, in the Journal: (JOURNAL) of 30/01/2022
- what: The authors explore the antitumor effect of KPT-330 combined with AZA in AML through CCK-8 flow cytometry RT-qPCR western blot and RNA-seq the results showed that KPT-330 combined with AZA synergistically reduced cell . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.